BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Francelle L, Galvan L, Gaillard MC, Petit F, Bernay B, Guillermier M, Bonvento G, Dufour N, Elalouf JM, Hantraye P, Déglon N, de Chaldée M, Brouillet E. Striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo. Neurobiol Aging 2015;36:1601.e7-16. [PMID: 25619660 DOI: 10.1016/j.neurobiolaging.2014.11.014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Pellegrini M, Bergonzoni G, Perrone F, Squitieri F, Biagioli M. Current Diagnostic Methods and Non-Coding RNAs as Possible Biomarkers in Huntington’s Disease. Genes 2022;13:2017. [DOI: 10.3390/genes13112017] [Reference Citation Analysis]
2 Ghafouri-fard S, Khoshbakht T, Hussen BM, Taheri M, Ebrahimzadeh K, Noroozi R. The emerging role of long non-coding RNAs, microRNAs, and an accelerated epigenetic age in Huntington’s disease. Front Aging Neurosci 2022;14:987174. [DOI: 10.3389/fnagi.2022.987174] [Reference Citation Analysis]
3 Golla U, Sesham K, Dallavalasa S, Manda NK, Unnam S, Sanapala AK, Nalla S, Kondam S, Kumar R. ABHD11-AS1: An Emerging Long Non-Coding RNA (lncRNA) with Clinical Significance in Human Malignancies. ncRNA 2022;8:21. [DOI: 10.3390/ncrna8020021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bhattacharyya N, Pandey V, Bhattacharyya M, Dey A. Regulatory role of long non coding RNAs (lncRNAs) in neurological disorders: From novel biomarkers to promising therapeutic strategies. Asian J Pharm Sci 2021;16:533-50. [PMID: 34849161 DOI: 10.1016/j.ajps.2021.02.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
5 Zhang M, He P, Bian Z. Long Noncoding RNAs in Neurodegenerative Diseases: Pathogenesis and Potential Implications as Clinical Biomarkers. Front Mol Neurosci 2021;14:685143. [PMID: 34421536 DOI: 10.3389/fnmol.2021.685143] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
6 Aryankalayil MJ, Martello S, Bylicky MA, Chopra S, May JM, Shankardass A, MacMillan L, Sun L, Sanjak J, Vanpouille-Box C, Eke I, Coleman CN. Analysis of lncRNA-miRNA-mRNA expression pattern in heart tissue after total body radiation in a mouse model. J Transl Med 2021;19:336. [PMID: 34364390 DOI: 10.1186/s12967-021-02998-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Dong X, Cong S. The emerging roles of long non-coding RNAs in polyglutamine diseases. J Cell Mol Med 2021. [PMID: 34318578 DOI: 10.1111/jcmm.16808] [Reference Citation Analysis]
8 Policarpo R, Sierksma A, De Strooper B, d'Ydewalle C. From Junk to Function: LncRNAs in CNS Health and Disease. Front Mol Neurosci 2021;14:714768. [PMID: 34349622 DOI: 10.3389/fnmol.2021.714768] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
9 Baptista B, Riscado M, Queiroz J, Pichon C, Sousa F. Non-coding RNAs: Emerging from the discovery to therapeutic applications. Biochemical Pharmacology 2021;189:114469. [DOI: 10.1016/j.bcp.2021.114469] [Reference Citation Analysis]
10 Cresto N, Gardier C, Gaillard MC, Gubinelli F, Roost P, Molina D, Josephine C, Dufour N, Auregan G, Guillermier M, Bernier S, Jan C, Gipchtein P, Hantraye P, Chartier-Harlin MC, Bonvento G, Van Camp N, Taymans JM, Cambon K, Liot G, Bemelmans AP, Brouillet E. The C-Terminal Domain of LRRK2 with the G2019S Substitution Increases Mutant A53T α-Synuclein Toxicity in Dopaminergic Neurons In Vivo. Int J Mol Sci 2021;22:6760. [PMID: 34201785 DOI: 10.3390/ijms22136760] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
11 Tan X, Liu Y, Liu Y, Zhang T, Cong S. Dysregulation of long non-coding RNAs and their mechanisms in Huntington's disease. J Neurosci Res 2021;99:2074-90. [PMID: 34031910 DOI: 10.1002/jnr.24825] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Tan X, Liu Y, Zhang T, Cong S. Integrated analysis of differentially expressed genes and construction of a competing endogenous RNA network in human Huntington neural progenitor cells. BMC Med Genomics 2021;14:48. [PMID: 33579286 DOI: 10.1186/s12920-021-00894-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Baptista B, Riscado M, Queiroz JA, Pichon C, Sousa F. Non-coding RNAs: Emerging from the discovery to therapeutic applications. Biochem Pharmacol 2021;189:114469. [PMID: 33577888 DOI: 10.1016/j.bcp.2021.114469] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
14 Wu YY, Kuo HC. Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases. J Biomed Sci. 2020;27:49. [PMID: 32264890 DOI: 10.1186/s12929-020-00636-z] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 36.0] [Reference Citation Analysis]
15 Bertogliat MJ, Morris-Blanco KC, Vemuganti R. Epigenetic mechanisms of neurodegenerative diseases and acute brain injury. Neurochem Int 2020;133:104642. [PMID: 31838024 DOI: 10.1016/j.neuint.2019.104642] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
16 Song Q, Geng Y, Li Y, Wang L, Qin J. Long noncoding RNA NORAD regulates MPP+-induced Parkinson's disease model cells. J Chem Neuroanat 2019;101:101668. [PMID: 31421205 DOI: 10.1016/j.jchemneu.2019.101668] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
17 Galvan L, Francelle L, Gaillard MC, de Longprez L, Carrillo-de Sauvage MA, Liot G, Cambon K, Stimmer L, Luccantoni S, Flament J, Valette J, de Chaldée M, Auregan G, Guillermier M, Joséphine C, Petit F, Jan C, Jarrige M, Dufour N, Bonvento G, Humbert S, Saudou F, Hantraye P, Merienne K, Bemelmans AP, Perrier AL, Déglon N, Brouillet E. The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin. Brain 2018;141:1434-54. [PMID: 29534157 DOI: 10.1093/brain/awy057] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
18 Zhao MY, Wang GQ, Wang NN, Yu QY, Liu RL, Shi WQ. The long-non-coding RNA NEAT1 is a novel target for Alzheimer's disease progression via miR-124/BACE1 axis. Neurol Res 2019;41:489-97. [PMID: 31014193 DOI: 10.1080/01616412.2018.1548747] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 17.7] [Reference Citation Analysis]
19 Lo Piccolo L. Drosophila as a Model to Gain Insight into the Role of lncRNAs in Neurological Disorders. Adv Exp Med Biol 2018;1076:119-46. [PMID: 29951818 DOI: 10.1007/978-981-13-0529-0_8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
20 Chanda K, Das S, Chakraborty J, Bucha S, Maitra A, Chatterjee R, Mukhopadhyay D, Bhattacharyya NP. Altered Levels of Long NcRNAs Meg3 and Neat1 in Cell And Animal Models Of Huntington's Disease. RNA Biol 2018;15:1348-63. [PMID: 30321100 DOI: 10.1080/15476286.2018.1534524] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
21 Cipolla GA, de Oliveira JC, Salviano-Silva A, Lobo-Alves SC, Lemos DS, Oliveira LC, Jucoski TS, Mathias C, Pedroso GA, Zambalde EP, Gradia DF. Long Non-Coding RNAs in Multifactorial Diseases: Another Layer of Complexity. Noncoding RNA 2018;4:E13. [PMID: 29751665 DOI: 10.3390/ncrna4020013] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 8.3] [Reference Citation Analysis]
22 Chen M, Li J, Zhuang C, Cai Z. Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer. Oncotarget 2017;8:28176-86. [PMID: 28157695 DOI: 10.18632/oncotarget.14945] [Cited by in Crossref: 24] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
23 Hu G, Niu F, Humburg BA, Liao K, Bendi S, Callen S, Fox HS, Buch S. Molecular mechanisms of long noncoding RNAs and their role in disease pathogenesis. Oncotarget. 2018;9:18648-18663. [PMID: 29719633 DOI: 10.18632/oncotarget.24307] [Cited by in Crossref: 97] [Cited by in F6Publishing: 104] [Article Influence: 24.3] [Reference Citation Analysis]
24 Wang DQ, Fu P, Yao C, Zhu LS, Hou TY, Chen JG, Lu Y, Liu D, Zhu LQ. Long Non-coding RNAs, Novel Culprits, or Bodyguards in Neurodegenerative Diseases. Mol Ther Nucleic Acids 2018;10:269-76. [PMID: 29499939 DOI: 10.1016/j.omtn.2017.12.011] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 8.0] [Reference Citation Analysis]
25 Bassi S, Tripathi T, Monziani A, Di Leva F, Biagioli M. Epigenetics of Huntington's Disease. Adv Exp Med Biol 2017;978:277-99. [PMID: 28523552 DOI: 10.1007/978-3-319-53889-1_15] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
26 Navia-Paldanius D, Patel JZ, López Navarro M, Jakupović H, Goffart S, Pasonen-Seppänen S, Nevalainen TJ, Jääskeläinen T, Laitinen T, Laitinen JT, Savinainen JR. Chemoproteomic, biochemical and pharmacological approaches in the discovery of inhibitors targeting human α/β-hydrolase domain containing 11 (ABHD11). Eur J Pharm Sci 2016;93:253-63. [PMID: 27544863 DOI: 10.1016/j.ejps.2016.08.031] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
27 Zhong J, Jiang L, Cheng C, Huang Z, Zhang H, Liu H, He J, Cao F, Peng J, Jiang Y, Sun X. Altered expression of long non-coding RNA and mRNA in mouse cortex after traumatic brain injury. Brain Res 2016;1646:589-600. [PMID: 27380725 DOI: 10.1016/j.brainres.2016.07.002] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 9.0] [Reference Citation Analysis]
28 Sunwoo JS, Lee ST, Im W, Lee M, Byun JI, Jung KH, Park KI, Jung KY, Lee SK, Chu K, Kim M. Altered Expression of the Long Noncoding RNA NEAT1 in Huntington's Disease. Mol Neurobiol 2017;54:1577-86. [PMID: 27221610 DOI: 10.1007/s12035-016-9928-9] [Cited by in Crossref: 101] [Cited by in F6Publishing: 89] [Article Influence: 16.8] [Reference Citation Analysis]
29 Wan P, Su W, Zhuo Y. The Role of Long Noncoding RNAs in Neurodegenerative Diseases. Mol Neurobiol 2017;54:2012-21. [PMID: 26910817 DOI: 10.1007/s12035-016-9793-6] [Cited by in Crossref: 103] [Cited by in F6Publishing: 96] [Article Influence: 17.2] [Reference Citation Analysis]
30 Sin O, Nollen EA. Regulation of protein homeostasis in neurodegenerative diseases: the role of coding and non-coding genes. Cell Mol Life Sci 2015;72:4027-47. [PMID: 26190021 DOI: 10.1007/s00018-015-1985-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]